Skip to main content
Advanced Search
Search Terms
Content Type

Exact Matches
Tag Searches
Date Options
Updated after
Updated before
Created after
Created before

Search Results

7273 total results found

22 - 29.22 Monoamine Oxidase Inhibitors

Kaplan 34 - 29 Psychopharmacological Treatment

29.22 Monoamine Oxidase Inhibitors 9th edition. Vol. 2. Philadelphia: Lippincott Williams & Wilkins: 2009:3152. 29.22 Monoamine Oxidase Inhibitors Introduced in the late 1950s, MAOIs were the first class of approved antidepressant drugs. The first of these dru...

23 - 29.23 Nefazodone and Trazodone

Kaplan 34 - 29 Psychopharmacological Treatment

29.23 Nefazodone and Trazodone antidepressant drug treatments. Brain Res. 2008;1211:37. Baker GB, Sowa S, Todd KG. Amine oxidases and their inhibitors: What can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders? J P...

24 - 29.24 Opioid Receptor Agonists

Kaplan 34 - 29 Psychopharmacological Treatment

29.24 Opioid Receptor Agonists randomized double-blind placebo-controlled trial. Addiction. 2005;100(4):489. Sasada K, Iwamoto K, Kawano N, et al. Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function ...

25 - 29.25 Opioid Receptor Antagonists Naltrexone,

Kaplan 34 - 29 Psychopharmacological Treatment

29.25 Opioid Receptor Antagonists: Naltrexone, Nalmefene, and Naloxone Strain EC, Moody DE, Stoller KB, Walsh SL, Bigelow GE. Relative bioavailability of different buprenorphine formulations under chronic dosing conditions. Drug Alcohol Depend. 2004;74:37. Sub...

26 - 29.26 Phosphodiesterase 5 Inhibitors

Kaplan 34 - 29 Psychopharmacological Treatment

29.26 Phosphodiesterase-5 Inhibitors King A, De Wit H, Riley RC, Cao D, Niaura R. Efficacy of naltrexone in smoking cessation: A preliminary study and an examination of sex differences. Nicotine Tobacco Res. 2006;8(5):671. Krishnan-Sarin S, Rounsaville BJ, O’M...

27 - 29.27 Selective SerotoninNorepinephrine Reupt

Kaplan 34 - 29 Psychopharmacological Treatment

29.27 Selective Serotonin–Norepinephrine Reuptake Inhibitors Assoc Nurses AIDS Care. 2013;24(1 Suppl):S135–S145. Tuncel A, Nalcacioglu V, Ener K, Aslan Y, Aydin O, Atan A. Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating...

28 - 29.28 Selective Serotonin Reuptake Inhibitors

Kaplan 34 - 29 Psychopharmacological Treatment

29.28 Selective Serotonin Reuptake Inhibitors Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in t...

29 - 29.29 SerotoninDopamine Antagonists and Simil

Kaplan 34 - 29 Psychopharmacological Treatment

29.29 Serotonin–Dopamine Antagonists and Similarly Acting Drugs (Second-Generation or Atypical Antipsychotics) Comprehensive Textbook of Psychiatry. 9th ed. Vol. 2. Philadelphia: Lippincott Williams & Wilkins; 2009:3190. Thase ME, Haight BR, Richard N, Rockett...

30 - 29.30 Stimulant Drugs and Atomoxetine

Kaplan 34 - 29 Psychopharmacological Treatment

29.30 Stimulant Drugs and Atomoxetine Suzuki H, Gen K, Inoue Y. Comparison of the anti-dopamine D(2) and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereo...

31 - 29.31 Thyroid Hormones

Kaplan 34 - 29 Psychopharmacological Treatment

29.31 Thyroid Hormones McElroy SL, Guerdjikova A, Kotwal R, Weige JA, Nelson EB. Atomoxetine in the treatment of binge-eating disorder: A randomized placebo-controlled trial. J Clin Psychiatry. 2007;68(3):390. Minzenberg MJ, Carter CS. Modafinil: A review of n...

32 - 29.32 Tricyclics and Tetracyclics

Kaplan 34 - 29 Psychopharmacological Treatment

29.32 Tricyclics and Tetracyclics risk for postpartum depressive symptoms. Psychoneuroendocrinology. 2013;38(7):1007–1013. 29.32 Tricyclics and Tetracyclics The observation in 1957 that imipramine (Tofranil) had antidepressant effects led to the development of...

33 - 29.33 Valproate

Kaplan 34 - 29 Psychopharmacological Treatment

29.33 Valproate Psychiatry. 1990;47:1093. Lai MW, Klein-Schwartz W, Rodgers GC, Abrams JY, Haber DA. 2005 Annual report of the American Association of Poison Control Centers’ national poisoning and exposure database. Clin Toxicol. 2006;44:803. Lapierre YD. A r...

34 - 29.34 Nutritional Supplements and Medical Foo

Kaplan 34 - 29 Psychopharmacological Treatment

29.34 Nutritional Supplements and Medical Foods 29.34 Nutritional Supplements and Medical Foods Thousands of herbal and dietary supplements are being marketed today. Some are purported to have psychoactive properties. A number have even shown promise in the tr...

35 - 29.35 Weight Loss Drugs

Kaplan 34 - 29 Psychopharmacological Treatment

29.35 Weight Loss Drugs REFERENCES Camp KM, Lloyd-Puryear MA, Huntington KL. Nutritional treatment for inborn errors of metabolism: Indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example. Mol Gen...

01 - 30.1 Electroconvulsive Therapy

Kaplan 35 - 30 Brain Stimulation Methods

30.1 Electroconvulsive Therapy Brain Stimulation Methods 30.1 Electroconvulsive Therapy Convulsive therapies for major psychiatric illnesses predate the modern therapeutic era, with the use of camphor reported as early as the 16th century and the existence of ...

02 - 30.2 Other Brain Stimulation Methods

Kaplan 35 - 30 Brain Stimulation Methods

30.2 Other Brain Stimulation Methods Psychiatry. 9th ed. Vol. 2. Philadelphia: Lippincott Williams & Wilkins; 2009:3285. Prudic J. Strategies to minimize cognitive side effects with ECT: Aspects of ECT technique. J ECT. 2008;24:46. Rapinesi C, Serata D, Casale...

03 - 30.3 Neurosurgical Treatments and Deep Brain

Kaplan 35 - 30 Brain Stimulation Methods

30.3 Neurosurgical Treatments and Deep Brain Stimulation Luber B, Kinnunen LH, Rakitin BC, Ellsasser R, Stern Y. Facilitation of performance in a working memory task with rTMS stimulation of the precuneus: Frequency- and time-dependent effects. Brain Res. 2007...

01 - 31.1 Introduction Infant, Child, and Adolesce

Kaplan 36 - 31 Child Psychiatry

31.1 Introduction: Infant, Child, and Adolescent Development Child Psychiatry 31.1 Introduction: Infant, Child, and Adolescent Development The transactional nature of development in infancy, childhood, and adolescence, consisting of a continuous interplay betw...